The current status and future of theranostic Copper-64 radiopharmaceuticals

Abstract

Copper-64 was produced in large scales and high specific activities in late 1990s’ using compact cyclotrons based by 64Ni(p,n)64Cu reaction and many radiopharmaceuticals developed since then by various groups based on interesting physicochemical and nuclear properties of the radionuclide. The unique emission of beta particles as well as positron particles… (More)

Topics

13 Figures and Tables

Cite this paper

@inproceedings{Jalilian2016TheCS, title={The current status and future of theranostic Copper-64 radiopharmaceuticals}, author={Amir Reza Jalilian}, year={2016} }